PADI4-IN-1 is a potent inhibitor of peptidyl arginine deiminase 4 (PADI4), with an IC50 value of 1.5 µM and a selectivity index (SI) of 52.1 [PADI1/PADI4]. It effectively suppresses cellular citrullination events and can be utilized in research related to inflammation, such as rheumatoid arthritis.
Target:
PAD
* VAT and and shipping costs not included. Errors and price changes excepted